Kinga Czarnecka

Are We on the Right Track for HCV Micro-Elimination? HCV Management Practices in Dialysis Centers in Poland—A National Cross-Sectional Survey

M. Durlik, Weronika Zarychta-Wiśniewska, T. Bączkowska, 2023, Journal of clinical medicine.

Utilization of HCV viremic donors in kidney transplantation: a chance or a threat?

M. Durlik, T. Bączkowska, O. Tronina, 2022, Renal failure.

Multidirectional facets of obesity management in the metabolic syndrome population after liver transplantation

M. Durlik, T. Bączkowska, O. Tronina, 2021, Immunity, inflammation and disease.

Real-life comparison of efficacy and safety profiles of two prolonged-release tacrolimus formulations in de novo kidney transplant recipients: 24 months of follow-up

M. Durlik, B. Lagiewska, T. Bączkowska, 2023, PloS one.

Evaluation of Long-Term Outcomes of Direct Acting Antiviral Agents in Chronic Kidney Disease Subjects: A Single Center Cohort Study

M. Durlik, T. Bączkowska, O. Tronina, 2023, Journal of clinical medicine.

Metabolic Profile of Liver Transplant Recipients and Determinants of their Body Fat Distribution

A. Jagielska, M. Durlik, T. Bączkowska, 2023, Obesities.

De Novo Metabolic Syndrome 1 Year after Liver Transplantation and Its Association with Mid- and Long-Term Morbidity and Mortality in Liver Recipients

T. Bączkowska, O. Tronina, P. Czarnecka, 2024, Journal of clinical medicine.

Molnupiravir Outpatient Treatment for Adults with COVID-19 in a Real-World Setting—A Single Center Experience

M. Durlik, O. Tronina, P. Czarnecka, 2022, Journal of clinical medicine.